LEADER SPOTLIGHT
Marcin Staniszewski
Chief Executive Officer
“We are dedicated to revolutionizing healthcare through advanced optical sensing technologies. At SDS Optic, we specialize in developing novel cancer diagnostic solutions that enable, real-time detection of biomarkers. By integrating state-of-the-art research, innovation, and interdisciplinary expertise, we aim to improve clinical outcomes and empower healthcare providers with cutting-edge tools for early and accurate cancer diagnosis."
Our mission
We are committed to addressing unmet diagnostic and general labolatory needs in oncology and infectious diseases by advancing and optimizing current biomarker technologies. Our mission is to improve patient outcomes by providing innovative, biomarker based diagnostic solutions that benefit patients, healthcare providers, and payors alike.
Corporate video
State-of-the-Art Manufacturing & R&D Facilities
Our advanced facilities drive innovation and precision in biosensor technology, optoelectronics, and molecular biology research. From our headquarters and R&D center, where we develop inPROBE sensors and monoclonal antibodies, to our Philadelphia laboratory, specializing in novel protein and biomarker research, we are committed to scientific excellence. With a dedicated clean room, a $1M machine park for photonic component production, and the capacity to manufacture over 50,000 biosensors annually, we ensure quality and scalability at every stage.
Lublin HQ and R&D Center
Specialized production of inPROBE sensors, coupled with R&D in optoelectronics and molecular biology. Strong small-scale capabilities in monoclonal antibody production and the development of diagnostic platforms in infectious diseases.
Philadelphia Lab
Focus on developing novel proteins and biomarkers for cancer and eye research programs, including protein cloning, expression, purification, and characterization to assess their properties and specificity
SDS Optic Group Capital Structure
As of the end of December 2024, SDS Optic S.A. is the parent company of two subsidiaries, FiBioMed Sp. z o.o. and SDS Optic Inc., in which it holds majority stakes
Dedicated Clean Room production and quality control facility compliant with EN ISO 14644
Own machine park valued at approximately $1M for the production of photonic components for the inPROBE biosensors
Ability to scale up production from laboratory to semi-industrial scale with full control of the quality of all production processes and planned production capacity of over 50,000 biosensors per year
Confirmed compliance of process, technological, and manufacturing documentation audit by Orange (photonic division)
Aligning science and experience to change the world
Marcin Staniszewski
Chief Executive Officer
Magdalena Staniszewska, PhD, Professor
Chief Scientific Officer
Dariusz Stencel, MD, PhD
Chief Medical Officer
Marta Gęca
Financial Controller
Joanna Brońska-Stąsik
Quality and Regulatory Director, PRRC
Anna Uherek
Business Development Director
Alexandra Monroy, PhD
Principal Researcher
Karol Maryniowski
Marketing, Communications and IR Manager
Katarzyna Furman
R&D Project ManagerSupervisory Board
Krzysztof Klimkowski
Chair of the Supervisory Board
Łukasz Kowalczyk
Member of the Supervisory Board
Marcin Bielówka
Member of the Supervisory Board
Marcin Molo
Member of the Supervisory Board
Marcin Warzynowicz
Member of the Supervisory BoardWe Care About Your Privacy
SDS Optic S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.